Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

(TEVA)
  Report
Real-time Estimate Cboe BZX  -  03:18 2022-10-04 pm EDT
8.715 USD   +5.89%
10/03Teva Reaches Agreement with Georgia to Settle the State's Price Fixing Claims
AQ
09/30Sector Update: Health Care Stocks Weaken With Broader Markets
MT
09/30Sector Update: Health Care Stocks Still Looking to Establish Friday Direction
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Spotify, Alphabet rise; Kraft Heinz, Garmin fall

07/27/2022 | 04:26pm EDT

Stocks that traded heavily or had substantial price changes Wednesday:

Teva Pharmaceutical Industries Ltd., up $2.02 to $9.14.

The drugmaker agreed to a $4.3 billion settlement to settle lawsuits that claimed the company helped fuel the U.S. opioid epidemic.

Alphabet Inc., up $8.04 to $113.06.

Google's owner reported second-quarter results that weren’t as bad as investors feared.

Spotify Technology SA, up $12.64 to $116.61.

The music streaming service's monthly active user and premium subscriber numbers exceeded the Street's expectations.

Chipotle Mexican Grill Inc., up $193.57 to $1,510.

The restaurant chain reported second-quarter earnings that beat analysts' forecasts, helped by higher margins and lower expenses.

Sherwin-Williams Co., down $22.32 to $231.97.

The paint and coatings maker lowered its earnings outlook after its results fell short of Wall Street's estimates.

Kraft Heinz Co., down $2.30 to $36.34.

The maker of Jell-O pudding and Velveeta cheese reported strong second-quarter financial results, but year-over-year margins fell.

Garmin Ltd., down $8.94 to $93.56.

The bike computer and fitness watch maker reported revenue growth that fell short of Wall Street's estimates.

Enphase Energy Inc., up $38.67 to $254.77.

The solar technology company delivered second-quarter results that topped analysts' forecasts, reflecting strong demand in Europe.

Copyright 2022 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission., source Associated Press News

Stocks mentioned in the article
ChangeLast1st jan.
ALPHABET INC. 3.07% 101.6174 Delayed Quote.-31.90%
GARMIN LTD. 1.14% 83.32 Delayed Quote.-39.51%
SPOTIFY TECHNOLOGY S.A. 6.06% 94.46 Delayed Quote.-61.97%
TEVA PHARMACEUTICAL INDUSTRIES LIMITED 6.14% 8.725 Delayed Quote.0.75%
THE KRAFT HEINZ COMPANY 1.38% 34.405 Delayed Quote.-5.40%
All news about TEVA PHARMACEUTICAL INDUSTRIES LIMITED
10/03Teva Reaches Agreement with Georgia to Settle the State's Price Fixing Claims
AQ
09/30Sector Update: Health Care Stocks Weaken With Broader Markets
MT
09/30Sector Update: Health Care Stocks Still Looking to Establish Friday Direct..
MT
09/30Teva Pharmaceutical Reaches Agreement with Georgia to Settle Price-Fixing Claims
MT
09/30Teva Reaches Agreement With Georgia to Settle the State's Price Fixing Claims
BU
09/30Immuneering Announces FDA Clearance of IND Application for Phase 1/2a Clinical Trial of..
AQ
09/30Teva Pharmaceutical Reaches Third State Settlement Over Price-Fixing Claims
DJ
09/27Teva Launches Honestly HD Website to Provide People Living With Huntington's Disease (H..
AQ
09/26Teva Launches Honestly HD Website to Provide People Living With Huntington's Disease (H..
BU
09/19IMMUNEERING CORP Change in Directors or Principal Officers (form 8-K/A)
AQ
More news
Analyst Recommendations on TEVA PHARMACEUTICAL INDUSTRIES LIMITED
More recommendations
Financials (USD)
Sales 2022 15 331 M - -
Net income 2022 -487 M - -
Net Debt 2022 19 346 M - -
P/E ratio 2022 -18,3x
Yield 2022 -
Capitalization 9 140 M 9 140 M -
EV / Sales 2022 1,86x
EV / Sales 2023 1,68x
Nbr of Employees 35 346
Free-Float 89,8%
Chart TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Duration : Period :
Teva Pharmaceutical Industries Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 8,23 $
Average target price 10,56 $
Spread / Average Target 28,3%
EPS Revisions
Managers and Directors
Kåre Schultz President, Chief Executive Officer & Director
Eli Kalif Chief Financial Officer & Executive Vice President
Sol J. Barer Chairman
Eric A. Hughes Chief Medical Officer, Executive VP-Global R&D
Eric Drapé SVP-Technical Operations Steriles & Respiratory
Sector and Competitors
1st jan.Capi. (M$)
TEVA PHARMACEUTICAL INDUSTRIES LIMITED0.75%9 140
JOHNSON & JOHNSON-4.60%429 082
ELI LILLY AND COMPANY17.06%305 529
ROCHE HOLDING AG-15.04%267 122
PFIZER, INC.-25.25%247 729
ABBVIE INC.2.16%244 563